Antiva Biosciences
Biotechnology, 280 Old County Rd 257, South San Francisco, California, 94005, United States, 11-50 Employees
Who is ANTIVA BIOSCIENCES
Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. We aim to stop cancer ...
Read More
-
Headquarters: 280 Old County Rd 257, South San Francisco, California, 94005, United States
-
Date Founded: 2012
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
-
CEO:
Kristine Ball
Email
Phone
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from ANTIVA BIOSCIENCES
Antiva Biosciences Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Antiva Biosciences
Answer: Antiva Biosciences's headquarters are located at 280 Old County Rd 257, South San Francisco, California, 94005, United States
Answer: Antiva Biosciences's official website is https://antivabio.com
Answer: Antiva Biosciences's revenue is $1 Million to $5 Million
Answer: Antiva Biosciences's SIC: 2836
Answer: Antiva Biosciences's NAICS: 541714
Answer: Antiva Biosciences has 11-50 employees
Answer: Antiva Biosciences is in Biotechnology
Answer: Antiva Biosciences contact info: Phone number: Website: https://antivabio.com
Answer: Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. We aim to stop cancer before it starts by treating the pre-cancerous lesions caused by HPV. Our lead programs are in clinical trials in high grade anal intraepithelial neoplasias (AIN 2,3) and high grade cervical intraepithelial neoplasias (CIN 2,3). The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego and builds on his anti-viral expertise as co-founder of Triangle Pharmaceuticals and Chimerix. Antivas chemistry platform has yielded over two hundred proprietary pro-drug compounds that are designed to enhance the therapeutic index of known, potent antivirals.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month